Samplix Launches Xdrop™ – Providing PCR-free Target Enrichment of Single Molecules

Herlev, Denmark – September 2nd 2019 – Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity. Xdrop™ enables single molecule resolution and bias free enrichment of genomic regions longer than 100 kb from as little as 1 ng genomic DNA. Xdrop™ fits seamlessly with any... Read more

Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation

Fluidigm Launches Breakthrough RNA Sequencing Library Preparation Workflow, Delivering Substantial Cost Savings and Efficiency SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of a breakthrough RNA sequencing library preparation workflow that provides substantial cost savings... Read more

European Research Initiative Adopts PacBio Sequel II System to Solve Rare Diseases

MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology has been selected by the European research program SOLVE-RD to help reveal the genetic mechanisms responsible for rare genetic... Read more

Samplix Launches Xdrop™ – Providing PCR-free Target Enrichment of Single Molecules

Pictured: The Xdrop™ system from Samplix. To download this image, please click here. Herlev, Denmark – September 2nd 2019 – Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.  Xdrop™ enables single molecule resolution and bias free enrichment of genomic regions longer than 100 kb from... Read more

Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing its Life Science business’ patent… 19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents... Read more

Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents to date across nine different geographies Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual... Read more

Reforest the Tropics and New England Biolabs®, Inc. enter into agreement to plant 100 hectares of forest to offset carbon emissions

Mystic, CT and Ipswich, MA (August 15, 2019): Reforest The Tropics (RTT), a 501(c)(3) non-profit organization based in Mystic, Connecticut and New England Biolabs, Inc. (NEB®), a global leader in the production of reagents for the life science industry, announce that they have entered into an agreement to plant 100 hectares (247 acres) of new tropical... Read more

IDT launches oPools™ Oligo Pools – the longest, highest fidelity, and ready-to-use custom oligo pools on the market

Aug 15, 2019 Long, high-yield oligos with industry-beating low error rate enable researchers to skip amplification steps and start projects immediately CORALVILLE, IA (August 15, 2019) – Continuing its mission to advance biological research worldwide, Integrated DNA Technologies (IDT) has launched oPools™ Oligo Pools – ready-to-use pools of high quality DNA oligonucleotides (oligos) up to 350 nucleotides in length. Thanks... Read more

Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications

Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY, August 5, 2019 — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and... Read more

IDT and Clear Labs ink multi-year supplier agreement to improve food safety through NGS-based testing technology

Jul 25, 2019 Clear Labs chooses IDT’s NGS oligo products for use in groundbreaking NGS-based food safety platform CORALVILLE, IA (July 25, 2019) – As part of its ongoing mission to break down the barriers in genomics research, Integrated DNA Technologies (IDT) is extending its network of collaborations into food quality and safety. Through a new multi-year supplier agreement,... Read more